Nadelmyografische Untersuchungen antikoagulierter Patienten, unter besonderer Berücksichtigung der neuen oralen Antikoagulanzien

Lernziele

Kenntnis der:

• grundsätzlichen Eigenschaften der neuen oralen Antikoagulanzien

• Empfehlungen zur Durchführung von Nadelmyografien unter Antikoagulation und Risikoabschätzung solcher Untersuchungen

• Vorgehensweise beim Auftreten klinisch symptomatischer Blutungen nach Nadelmyografien beim antikoagulierten Patienten

• Literatur

• 1 Gruis KL, Little AA, Zebarah VA et al. Survey of electrodiagnostic laboratories regarding hemorrhagic complications from needle electromyography. Muscle Nerve 2006; 34: 356-358
• 2 Heidbuchel H, Verhamme P, Alings M et al. European Heart Rhythm Association Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation. Europace 2013; 15: 625-651
• 3 Adam SS, McDuffie JR, Lachiewicz PF et al. Comparative effectiveness of new oral anticoagulants and standard thromboprophylaxis in patients having total hip or knee replacement: a systematic review. Ann Int Med 2013; 159: 275-284
• 4 van Ryn J, Stangier J, Haertter S et al. Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: interpretation of coagulation assays and reversal of anticoagulant activity. Thromb Haemostas 2010; 103: 1116-1127
• 5 Farrell CM, Rubin DI, Haidukewych GJ. Acute compartment syndrome of the leg following diagnostic electromyography. Muscle Nerve 2003; 27: 374-377
• 6 Caress JB, Rutkove SB, Carlin M et al. Paraspinal muscle hematoma after electromyography. Neurology 1996; 47: 269-272
• 7 London Z, Quint DJ, Haig AJ et al. The risk of hematoma following extensive electromyography of the lumbar paraspinal muscles. Muscle Nerve 2012; 46: 26-30
• 8 Rosioreanu A, Dickson A, Lypen S et al. Pseudoaneurysm of the calf after electromyography: sonographic and CT angiographic diagnosis. AJR 2005; 185: 282-283
• 9 Butler ML, Dewan RW. Subcutaneous hemorrhage in a patient receiving anticoagulant therapy: an unusual EMG complication. Arch Physical Med Rehabil 1984; 65: 733-734
• 10 Vaienti L, Vourtsis S, Urzola V. Compartment syndrome of the forearm following an electromyographic assessment. J Hand Surg 2005; 30: 656-657
• 11 Baba Y, Hentschel K, Freeman WD et al. Large paraspinal and iliopsoas muscle hematomas. Arch Neurol 2005; 62: 1306
• 12 Lynch SL, Boon AJ, Smith J et al. Complications of needle electromyography: hematoma risk and correlation with anticoagulation and antiplatelet therapy. Muscle Nerve 2008; 38: 1225-1230
• 13 Gertken JT, Hunt CH, Chinea NIM et al. Risk of hematoma following needle electromyography of the paraspinal muscles. Muscle Nerve 2011; 44: 439-440
• 14 Boon AJ, Gertken JT, Watson JC et al. Hematoma risk after needle electromyography. Muscle Nerve 2011; 45: 9-12
• 15 Gertken JT, Patel AT, Boon AJ. Electromyography and anticoagulation. PM & R 2013; 5: S3-7
• 16 American Association of Electrodiagnostic Medicine. Guidelines in electrodiagnostic medicine. Risks in electrodiagnostic medicine. Muscle Nerve 1999; 8 (Suppl. 01) S53-69
• 17 Al-Shekhlee A, Shapiro BE, Preston DC. Iatrogenic complications and risks of nerve conduction studies and needle electromyography. Muscle Nerve 2003; 27: 517-526
• 18 Levi M, Eerenberg E, Kamphuisen PW. Bleeding risk and reversal strategies for old and new anticoagulants and antiplatelet agents. Journal of thrombosis and haemostasis: JTH 2011; 9: 1705-1712